
Context Therapeutics Boosts Team with Strategic Stock Option Push
Context Therapeutics, a Philadelphia-based biotech leader, offers 46,000 stock options to attract top talent. Options are set at $0.83 per share, with potential for significant value increase as therapeutic advances are made. The offer aligns with Nasdaq regulations but remains outside Context’s